The changes of cytoskeletal proteins in plasma of acrylamide-induced rats

Neurochem Res. 2006 Jun;31(6):751-7. doi: 10.1007/s11064-006-9079-x. Epub 2006 Jul 15.

Abstract

Acrylamide (ACR) is a known industrial neurotoxic chemical that can induce neurodegeneration. Cytoskeletal protein aggregation is a pathological hallmark of neurodegenerative disorders. This study was an initial exploration on cytoskeletal proteins in plasma as potential biomarkers of ACR neurotoxicity. Low and high ACR groups received 20 mg/kg and 40 mg/kg ACR by intraperitoneal injection in adult Wistar rats and control group received physiological saline. Rats were all killed after 8 weeks to evaluate the levels of neurofilament(NF)-L, NF-M, NF-H, beta-actin, alpha-tubulin, beta-tubulin, tau, MAP2 proteins in plasma using both SDS-PAGE and western blotting. Compared with the control, the levels of NF-L, NF-M, NF-H, beta-actin, tau, MAP2 proteins decreased and the level of alpha-tubulin increased in high ACR group, the levels of alpha-tubulin, beta-tubulin and MAP2 increased in low ACR group. The results suggested that the changes of these proteins might be relevant to the neurotoxicity of ACR. Some of the cytoskeletal proteins in plasma might be used as marker of biological effect in ACR induced neuropathy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acrylamide / toxicity*
  • Animals
  • Biomarkers / blood
  • Blotting, Western
  • Body Weight / drug effects
  • Cytoskeletal Proteins / blood*
  • Electrophoresis, Polyacrylamide Gel
  • Gait / drug effects
  • Male
  • Rats
  • Rats, Wistar

Substances

  • Biomarkers
  • Cytoskeletal Proteins
  • Acrylamide